Day 1 - Monday, 30 November 2020

Meeting category
Date(s)
24 Nov 2020 - 4 Dec 2020
Meeting type
Virtual
INTEREST 2020
Related Enduring Materials
Enduring Materials
Session 1 - Opening -
Impact of COVID-19 on HIV, Tuberculosis, and Malaria Epidemiology and Treatment Services Across Africa
HIV and Climate Change: the Research Opportunities
Q&A - Session 1 - Opening
Oral Abstract Presentations 1 -
Q&A - Oral Abstract Presentations 1
Day 2 - Tuesday, 1 December 2020
-
Session 2 -HIV Prevention
The ECHO Trial: What’s Next on Contraception and HIV: Policy, Practice, and Research?
Margaret Phiri Kasaro, MBChB, MSc
University of North Carolina Global Project Zambia (UNC GPZ), Zambia
Q&A - Session 2 - HIV Prevention
Mini-Oral Abstract Presentations 1 -
It is Better if you are Going to Test Yourself…”: Attitudes, Test Preferences and Challenges of HIV Self-Testing among Female Sex Workers in eThekwini, South Africa: the Siyaphanta study
Kedibone Sithole
#33
Q&A - Mini-Oral Abstract Presentations 1
Day 3 - Wednesday, 2 December 2020
Oral Abstract Presentations 2 -
Q&A - Oral Abstract Presentations 2
Day 4 - Thursday, 3 December 2020
Session 3 - Access to Medicines and TB -
What you Need to Know about Public-Health Licensing and Access to Medicines in Africa
TB State-of-the-Art: Implications for Africa
Q&A - Session 3 - Access to Medicines and TB
Mini-Oral Abstract Presentations 2 -
Q&A - Mini-Oral Abstract Presentations 2
Session 4 - STI and Implementation Science -
What’s New in Sexually Transmitted Infections and HIV in 2020
Rashida Ferrand, FRCP, PhD, FMed Sci
London School of Hygiene & Tropical Medicine, United Kingdom / Biomedical Research and Training Institute, Zimbabwe
Implementation Science - an African Perspective
Q&A - Session 4 - STI and Implementation Science
Day 5 - Friday, 4 December 2020
Session 5 - Distance Learning and Dolutegravir Controversy -
Dolutegravir and Weight Gain - Where are We?
Q&A - Session 5 - Distance Learning and Dolutegravir Controversy
Mini-Oral Abstract Presentations 3 -
Alarming Burden of Dual-Class HIV-1 Drug Resistance Among Adolescents Calls for Innovative Antiretroviral Strategies: Baseline Findings from the Ready-Study (EDCTP TMA 1027)
Armanda Nangmo
#25
Positive Effects of Intensified Preventive Calls/Home Visits on Early Retention Among Adults Newly Initiated on Antiretroviral Therapy in Zambézia Province, Mozambique
José Tique
#38
Q&A - Mini-Oral Abstract Presentations 3
IAS Session - Getting to the Heart of Stigma: What does it take to have an impact at scale?
PRE-WEEK - INTEREST 2020 -
ViiV - Exploring the Basics of Implementation Science in HIV
Grantspersonship NIADS/NIH/Fogarty
Peter Kilmarx, MD, FACP, FIDSA
John E. Fogarty International Center, National Institutes of Health, USA
JIAS - Session: How to write and submit a research manuscript: “publish or perish”
Marlène Bras
JIAS Executive Editor
Ann Grimsrud
JIAS Deputy Editor
Overview
Support
Endorsers